The discussion covered a lot of ground: from the value of #biodata (somewhere between "gold", sometimes "overly expensive" to somehow "free") over FAIRness of proprietary data to the requirements of public data (e.g., service quality and sustainability) without which not even large corporates would be able to work properly. FAIR refers to four principles for research infrastructures that become more important for the private sector as well: findable, accessible, interoperable, and reusable.